Revvity (RVTY) Goodwill, Acquisition, Earn Outs and Other Adjustments — Quarterly & Annual

Screener

Discontinued — last reported Q3 '25

Segments

By segment

Life Sciences$98M—

Other financials

Income statement

Revenue$711.1M+7.0%

Gross profit$387.7M+3.2%

Operating income$75.9M+5.1%

Net income$40.7M-3.6%

EPS (diluted)$0.36+2.9%

Balance sheet

Cash & equivalents$861.5M-24.3%

Total debt$3.9B+17.8%

Total equity$7.2B-5.9%

Total assets$12.0B-2.9%

Cash flow

Operating cash flow$115.2M-10.1%

CapEx$19.8M+23.7%

Free cash flow$95.5M-14.9%

Valuation

Market cap$12.83B+28.7%

Enterprise value$15.91B+28.6%

P/E53.5×+18.6×

P/S4.4×+0.9×

Profitability

Gross margin48.5%—

Operating margin12.4%-1.1pp

Net margin8.3%-2.1pp

FCF margin17%-1.9pp

Returns & leverage

Return on equity3.2%-0.5pp

Debt / equity0.5×+0.1×

Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept revv:GoodwillAcquisitionEarnOutsAndOtherAdjustments.

The source filing: Revvity’s 10-Q, filed November 4, 2025.

Filed: Nov 4, 2025
Fiscal quarter: Q3 FY2025
Calendar quarter: Q3 2025
Accession: 0000031791-25-000037

Line item	Life Sciences	Diagnostics	Consolidated
Balance at December 29, 2024	$4,541,467	$1,922,152	$6,463,619
Foreign currency translation	96,267	40,745	137,012
Acquisitions, earn-outs and other	98	(98)	—
Balance at September 28, 2025	$4,637,832	$1,962,799	$6,600,631

Item 1.Unaudited Financial Statements

FAQ

What is Revvity's goodwill, acquisition, earn outs and other adjustments?: Revvity (RVTY) reported goodwill, acquisition, earn outs and other adjustments of $0 in Q3 2025.

Ask your AI about Revvity's goodwill, acquisition, earn outs and other adjustments.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Harbor at dusk